REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Number of holders
391
Total 13F shares, excl. options
50,252,292
Shares change
+1,818,023
Total reported value, excl. options
$8,165,826,817
Value change
+$277,439,901
Put/Call ratio
120%
Number of buys
173
Number of sells
214
Price
$162.40

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2022

As of 30 Jun 2022 REPLIGEN CORP - COMMON STOCK (RGEN) had 494 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 50,252,292 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, WCM INVESTMENT MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, Artisan Partners Limited Partnership, and ALLIANCEBERNSTEIN L.P..
This table shows 494 institutional shareholders of the security as of 30 Jun 2022.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.